1. |
Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA, 2016, 315(8): 762-774.
|
2. |
Shapiro NI, Wolfe RE, Moore RB, et al. Mortality in emergency department sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med, 2003, 31(3): 670-675.
|
3. |
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA, 2016, 315(8): 801-810.
|
4. |
Perner A, Cecconi M, Cronhjort M, et al. Expert statement for the management of hypovolemia in sepsis. Intensive Care Med, 2018, 44(6): 791-798.
|
5. |
Prescott HC, Angus DC. Postsepsis morbidity. JAMA, 2018, 319(1): 91.
|
6. |
Reinhart K, Daniels R, Kissoon N, et al. Recognizing sepsis as a global health priority - a WHO resolution. N Engl J Med, 2017, 377(5): 414-417.
|
7. |
罗家庆. 连续性血液净化应用于 ICU 重症脓毒血症治疗临床疗效及安全性评价. 中国实用医药, 2016, 11(9): 124-125.
|
8. |
Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med, 2009, 361(21): 2066-2078.
|
9. |
Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med, 2006, 34(1): 15-21.
|
10. |
Kahn JM, Le T, Angus DC, et al. The epidemiology of chronic critical illness in the United States. Crit Care Med, 2015, 43(2): 282-287.
|
11. |
Christakos S, Veldurthy V, Patel N, et al. Intestinal regulation of calcium: vitamin d and bone physiology. Adv Exp Med Biol, 2017, 1033: 3-12.
|
12. |
Allgrove J. Physiology of calcium, phosphate, magnesium and vitamin D. Endocr Dev, 2015, 28: 7-32.
|
13. |
Christakos S, Dhawan P, Verstuyf A, et al. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev, 2016, 96(1): 365-408.
|
14. |
Bouillon R. Vitamin D and cardiovascular disorders. Osteoporos Int, 2019, 30(11): 2167-2181.
|
15. |
Vanherwegen AS, Gysemans C, Mathieu C. Regulation of immune function by vitamin D and its use in diseases of immunity. Endocrinol Metab Clin North Am, 2017, 46(4): 1061-1094.
|
16. |
Jiménez-Sousa MÁ, Martínez I, Medrano LM, et al. Vitamin D in human immunodeficiency virus infection: influence on immunity and disease. Front Immunol, 2018, 9: 458.
|
17. |
Mangin M, Sinha R, Fincher K. Inflammation and vitamin D: the infection connection. Inflamm Res, 2014, 63(10): 803-819.
|
18. |
de Haan K, Groeneveld AB, de Geus HR, et al. Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis. Crit Care, 2014, 18(6): 660.
|
19. |
Upala S, Sanguankeo A, Permpalung N. Significant association between vitamin D deficiency and sepsis: a systematic review and meta-analysis. BMC Anesthesiol, 2015, 15: 84.
|
20. |
Zhou W, Mao S, Wu L, et al. Association between vitamin D status and sepsis. Clin Lab, 2018, 64(4): 451-460.
|
21. |
杜晓敏, 戴科芳, 张瑞英, 等. 血清 25-羟维生素 D 水平对糖尿病合并脓毒症患者预后的影响. 中文科技期刊数据库(文摘版)医药卫生, 2021(2): 97.
|
22. |
孙斐. 急性胰腺炎患者血清 25-羟维生素 D 水平与预后的关系探讨. 中国实用乡村医生杂志, 2022, 29(12): 59-61, 65.
|
23. |
刘瑜, 黄方, 严妤函, 等. 血清 25-羟维生素 D 水平与急性胰腺炎预后的相关性. 医学研究生学报, 2021, 34(7): 706-711.
|
24. |
Trongtrakul K, Feemuchang C. Prevalence and association of vitamin D deficiency and mortality in patients with severe sepsis. Int J Gen Med, 2017, 10: 415-421.
|
25. |
Charoenngam N, Shirvani A, Reddy N, et al. Association of vitamin D status with hospital morbidity and mortality in adult hospitalized patients with COVID-19. Endocr Pract, 2021, 27(4): 271-278.
|
26. |
贾育梅, 赵永祯, 吴彩军. 血清 25-羟维生素 D 水平对急诊脓毒症患者预后的影响//《中华急诊医学杂志》编辑部. 第十三届组稿会暨第六届急诊医学青年论坛论文集. 北京: 2014: 48-51.
|
27. |
Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute, 2000.
|
28. |
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med, 2002, 21(11): 1539-1558.
|
29. |
Patsopoulos NA, Evangelou E, Ioannidis JP. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol, 2008, 37(5): 1148-1157.
|
30. |
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2011, 96(7): 1911-1930.
|
31. |
陈朝彦, 罗佐杰, 胡杰妤, 等. 维生素 D 缺乏与脓毒症预后相关性研究. 中国实用内科杂志, 2014, 34(11): 1087-1090.
|
32. |
Zajic P, Schnedl C, Valentin T, et al. Vitamin D status and overall and sepsis mortality in critically ill patients. Critical Care, 2013, 17(Suppl 2): 447.
|
33. |
Amrein K, Zajic P, Schnedl C, et al. Vitamin D status and its association with season, hospital and sepsis mortality in critical illness. Crit Care, 2014, 18(2): R47.
|
34. |
Takeuti FAC, Guimaraes FSF, Guimaraes PSF. Applications of vitamin D in sepsis prevention. Discov Med, 2018, 25(140): 291-297.
|
35. |
Trochoutsou AI, Kloukina V, Samitas K, et al. Vitamin-D in the immune system: genomic and non-genomic actions. Mini Rev Med Chem, 2015, 15(11): 953-963.
|
36. |
Wang TJ. Vitamin D and cardiovascular disease. Annu Rev Med, 2016, 67: 261-272.
|
37. |
Parekh D, Thickett DR, Turner AM. Vitamin D deficiency and acute lung injury. Inflamm Allergy Drug Targets, 2013, 12(4): 253-261.
|
38. |
Yang S, Li A, Wang J, et al. Vitamin D receptor: a novel therapeutic target for kidney diseases. Curr Med Chem, 2018, 25(27): 3256-3271.
|
39. |
Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. the ACCP/SCCM consensus conference committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 1992, 101(6): 1644-1655.
|
40. |
Nguyen HB, Eshete B, Lau KH, et al. Serum 1, 25-dihydroxyvitamin D: an outcome prognosticator in human sepsis. PLoS One, 2013, 8(5): e64348.
|